Abstract

Decorin (DCN) is one of the matricellular proteins that participate in normal cells’ function as well as in cancerogenesis. While its expression in primary tumours is well known, there is limited data about its expression in metastases. Furthermore, the post-transcriptional regulation of DCN is still questionable, although it is well accepted that it is an important mechanism of developing metastatic cancer. The aim of our study was to analyse the expression of DCN and its potential regulatory ncRNAs in metastatic colorectal carcinoma (CRC). Nineteen patients with metastatic CRC were included. Using qPCR, we analysed the expression of DCN, miR-200c and five lncRNAs (LUCAT1, MALAT1, lncTCF7, XIST, and ZFAS1) in lymph node and liver metastases in comparison to the invasive front and central part of a primary tumour. Our results showed insignificant upregulation of DCN and significant upregulation for miR-200c, MALAT1, lncTCF7 and ZFAS1 in metastases compared to the primary tumour. miR-200c showed a positive correlation with DCN, and the aforementioned lncRNAs exhibited a significant positive correlation with miR-200c expression in metastatic CRC. Our results suggest that DCN as well as miR-200c, MALAT1, lncTCF7 and ZFAS1 contribute to the development of metastases in CRC and that regulation of DCN expression in CRC by ncRNAs is accomplished in an indirect manner.

Highlights

  • Accepted: 6 January 2022Decorin (DCN) is one of the matricellular proteins belonging to the small leucine-rich proteoglycan family

  • We showed that the DCN gene is upregulated regardless of the presence of lymph node metastasis, and it was the only gene significantly associated with the presence of lymph node metastasis in CRC

  • The invasive front and the central part of CRC were available in all cases, whereas lymph node metastases were available in 15 and liver metastases in 10 cases

Read more

Summary

Introduction

Accepted: 6 January 2022Decorin (DCN) is one of the matricellular proteins belonging to the small leucine-rich proteoglycan family. DCN is transcribed and translated by fibroblasts, stressed vascular endothelial cells and smooth muscle cells [1] It was first discovered as a protein-decorating collagen fibre [2], but today it is known as an important regulator of collagen fibrillogenesis [3,4]. DCN binds to growth factors, such as TGFβ, but on the other side, it inhibits receptor tyrosine kinases, e.g., EGFR, IGF-IR and met [1,6]. The latter bioactivities have been attributed to evoke potent tumour repression [1]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call